JP2001508544A - インフルエンザに対する血清α−N−アセチルガラクトサミニダーゼの診断用および予後判定用ELISAアッセイ - Google Patents
インフルエンザに対する血清α−N−アセチルガラクトサミニダーゼの診断用および予後判定用ELISAアッセイInfo
- Publication number
- JP2001508544A JP2001508544A JP53105698A JP53105698A JP2001508544A JP 2001508544 A JP2001508544 A JP 2001508544A JP 53105698 A JP53105698 A JP 53105698A JP 53105698 A JP53105698 A JP 53105698A JP 2001508544 A JP2001508544 A JP 2001508544A
- Authority
- JP
- Japan
- Prior art keywords
- acetylgalactosaminidase
- serum
- influenza virus
- plasma
- influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01049—Alpha-N-acetylgalactosaminidase (3.2.1.49)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.インフルエンザをスクリーニングするために、血漿または血清中のα−N −アセチルガラクトサミニダーゼを検出する方法であって: a)インフルエンザウイルスα−N−アセチルガラクトサミニダーゼに対する ポリクローナル抗体またはモノクローナル抗体を用意し; b)これらの抗体で被覆したマイクロタイタープレートを用意し; c)血清または血漿をマイクロタイタープレートに添加し; d)インフルエンザウイルスα−N−アセチルガラクトサミニダーゼと反応性 である、アルカリホスファターゼー抗体コンジュゲートをマイクロタイタープレ ートに供給し; e)リン酸p−ニトロフェニルをマイクロタイタープレートに供給し;そして f)工程(a)〜(e)の結果として起きる反応を標準曲線と比較して、正常 な個体と比較したインフルエンザウイルスα−N−アセチルガラクトサミニダー ゼ量を判定する 工程を含む方法。 2.血漿または血清中のインフルエンザウイルスα−N−アセチルガラクトサ ミニダーゼを検出することによりインフルエンザ感染をスクリーニングするため の抗体サンドイッチ型ELISAキットであって: a)インフルエンザウイルスα−N−アセチルガラクトサミニダーゼに特異的 なポリクローナル抗体またはモノクローナル抗体で被覆した、マイクロタイター プレート; b)インフルエンザウイルスα−N−アセチルガラクトサミニダーゼと反応性 である、ポリクローナル抗体またはモノクローナル抗体−アルカリホスファター ゼコンジュゲート; c)リン酸p−ニトロフェニル;および d)抗原標準としてのインフルエンザウイルスα−N−アセチルガラクトサミ ニダーゼ を含むキット。 3.インフルエンザウイルス感染患者およびインフルエンザウイルスに感染し ていると疑われる者の血清または血漿中のα−N−アセチルガラクトサミニダー ゼ活性を測定する方法であって、α−N−アセチルガラクトサミニダーゼ活性を 含む血清または血漿を硫酸アンモニウム沈殿させて沈殿を生じさせ、次いでこの 沈殿をクエン酸リン酸緩衝液で透析し、次いで沈殿をp−ニトロフェニル−N− アセチル−α−D−ガラクトサミニドと共にインキュベートする工程を含む方法 。 4.インフルエンザウイルス感染患者およびインフルエンザウイルスに感染し ていると疑われる者の血清または血漿中の抗原としてのα−N−アセチルガラク トサミニダーゼ活性を測定するための酵素結合イムノソルベントアッセイ(EL ISA)法であって、インフルエンザα−N−アセチルガラクトサミニダーゼに 対するポリクローナル抗体またはモノクローナル抗体、α−N−アセチルガラク トサミニダーゼ(抗原として)を含む血清または血漿、抗体捕獲したマイクロタ イタープレート、およびアルカリホスファターゼー抗体コンジュゲートを用意し 、そしてマイクロタイタープレートを、血清または血漿、アルカリホスファター ゼー抗体コンジュゲート、および基質としてのリン酸p−ニトロフェニルと共に 段階的にインキュベートすることにより抗体サンドイッチ型ELISAアッセイ を行う工程を含む方法。 5.インフルエンザに対する抗体サンドイッチ型ELISAキットであって、 下記の構成要素: a)インフルエンザウイルスα−N−アセチルガラクトサミニダーゼに特異的 なポリクローナル抗体またはモノクローナル抗体で被覆した、マイクロタイター プレート; b)標準曲線用の1.30〜4.50nmol/分/mgの既知α−N−アセ チルガラクトサミニダーゼ活性を含む血清; c)被験抗原としてのインフルエンザウイルス感染患者血清/血漿(10μl );および d)モノクローナル抗体−アルカリホスファターゼコンジュゲート を含むキット。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/779,729 US5712104A (en) | 1995-06-07 | 1997-01-06 | Diagnostic and prognostic elisa assays of serum or plasma α-N-acetylgalactosaminidase for cancer |
US08/779,729 | 1997-01-06 | ||
US08/938,553 | 1997-09-26 | ||
US08/938,553 US5776671A (en) | 1996-03-19 | 1997-09-26 | Diagnostic and prognostic ELISA assays of serum α-N-acetylgalactosaminidase for influenza |
PCT/US1998/000245 WO1998030906A1 (en) | 1997-01-06 | 1998-01-05 | DIAGNOSTIC AND PROGNOSTIC ELISA ASSAY OF SERUM α-N-ACETYLGALACTOSAMINIDASE FOR INFLUENZA |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001508544A true JP2001508544A (ja) | 2001-06-26 |
JP3472583B2 JP3472583B2 (ja) | 2003-12-02 |
Family
ID=27119614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53105698A Expired - Fee Related JP3472583B2 (ja) | 1997-01-06 | 1998-01-05 | インフルエンザに対する血清α−N−アセチルガラクトサミニダーゼの診断用および予後判定用ELISAアッセイ |
Country Status (4)
Country | Link |
---|---|
US (1) | US5776671A (ja) |
JP (1) | JP3472583B2 (ja) |
AU (1) | AU5958498A (ja) |
WO (1) | WO1998030906A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022124331A1 (ja) * | 2020-12-08 | 2022-06-16 | 再生ファーマ株式会社 | マクロファージ活性化剤 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627396B1 (en) * | 1999-10-28 | 2003-09-30 | The Regents Of The University Of California | Influenza sensor |
CN102353792A (zh) * | 2011-07-07 | 2012-02-15 | 贵州大学 | 一种基于gpv p32蛋白的间接elisa试剂盒及制备方法 |
US20200360408A1 (en) * | 2017-08-07 | 2020-11-19 | Joe Emest BROWN | Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections |
-
1997
- 1997-09-26 US US08/938,553 patent/US5776671A/en not_active Expired - Lifetime
-
1998
- 1998-01-05 WO PCT/US1998/000245 patent/WO1998030906A1/en active Application Filing
- 1998-01-05 JP JP53105698A patent/JP3472583B2/ja not_active Expired - Fee Related
- 1998-01-05 AU AU59584/98A patent/AU5958498A/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022124331A1 (ja) * | 2020-12-08 | 2022-06-16 | 再生ファーマ株式会社 | マクロファージ活性化剤 |
Also Published As
Publication number | Publication date |
---|---|
US5776671A (en) | 1998-07-07 |
WO1998030906A1 (en) | 1998-07-16 |
JP3472583B2 (ja) | 2003-12-02 |
AU5958498A (en) | 1998-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cambridge et al. | Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. | |
Ruddy et al. | A stoichiometric assay for the fourth component of complement in whole human serum using EAC′ lagp and functionally pure human second component | |
Rao et al. | An avidin-biotin microELISA for rapid measurement of total and allergen-specific human IgE | |
Araujo et al. | Antigenemia in recently acquired acute toxoplasmosis | |
Söderbergh et al. | Adrenal autoantibodies and organ‐specific autoimmunity in patients with Addison's disease | |
US5712104A (en) | Diagnostic and prognostic elisa assays of serum or plasma α-N-acetylgalactosaminidase for cancer | |
Bollinger Jr et al. | Acid dissociation increases the sensitivity of p24 antigen detection for the evaluation of antiviral therapy and disease progression in asymptomatic human immunodeficiency virus-infected persons | |
JPH01150856A (ja) | 抗原および抗体の同時免疫定量法 | |
JP2009197033A (ja) | 抗hcvコア蛋白質モノクローナル抗体 | |
EP0311492B1 (fr) | Trousse et méthode de dosage immunométrique applicables à des cellules entières | |
US5998132A (en) | Method and apparatus for detecting cancer, influenza, or HIV based on α-N-acetyl-galactosaminidase detection | |
CN115398241A (zh) | 免疫球蛋白检测及相关治疗 | |
Walzer et al. | Humoral immunity in experimental Pneumocystis carinii infection. I. Serum and bronchial lavage fluid antibody responses in rats | |
JP2886983B2 (ja) | 固相試薬およびそれを用いた抗体の測定法 | |
WO1992008983A1 (en) | Hiv marker/aids vaccine | |
JP2000501931A (ja) | Hiv感染を早期に検出する方法 | |
FI90801C (fi) | Menetelmä anti-HIV:n määrittämiseksi, tarvikkeet sitä varten ja niiden käyttö tässä menetelmässä | |
EP0497825A1 (en) | ANTIVIRAL MATERIAL. | |
JP2001508544A (ja) | インフルエンザに対する血清α−N−アセチルガラクトサミニダーゼの診断用および予後判定用ELISAアッセイ | |
EP0667897B1 (fr) | Methode d'immunodosage specifique de la glutathion peroxydase plasmatique humaine | |
Döller et al. | Early diagnosis of Q fever: detection of immunoglobulin M by radioimmunoassay and enzyme immunoassay | |
JP3558645B2 (ja) | 甲状腺自己免疫疾患の臨床診断薬としてのポリクローナルヒト抗−hTg自己抗体の使用及び患者血清中での抗−hTg自己抗体の検出用添加薬 | |
JPH11500226A (ja) | 抗体産生の検出 | |
US6670117B2 (en) | Specificity in the detection of anti-rubella IgM antibodies | |
Hamaguchi et al. | Quantitation of nasal secretory IgA by enzyme-linked immunosorbent assay |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080912 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090912 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100912 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110912 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110912 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120912 Year of fee payment: 9 |
|
LAPS | Cancellation because of no payment of annual fees |